Calando Pharmaceuticals
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
225 S Lake Ave Fl 3, Pasadena, Californi...Phone Number
(626) 304-3400Website
www.calandopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Calando Pharmaceuticals
Calando Pharmaceuticals specializes in advancing RNAi therapy through its proprietary drug delivery system, RONDEL, which targets cancer treatment. The company is currently focused on hormone research, particularly HGH and HCG, in relation to sports medicine and healthy lifestyles. Their lead product, CALAA-01, is undergoing a Phase 1 clinical trial at UCLA Medical Center and START in San Antonio, Texas. Calando aims to provide effective and safe systemic delivery methods to meet the pressing needs of the health research sector.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calando Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Calando Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Calando Pharmaceuticals has new funding data
Earning: See what the market has to say on Calando Pharmaceuticals recently announced quarterly report
Click to see if Calando Pharmaceuticals had a recent Job posting/layoffs
Check if Calando Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Calando Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Calando Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Calando Pharmaceuticals
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Calando Pharmaceuticals
Compare insights from companies similar to Calando Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Calando Pharmaceuticals
<$5M
11-50
Private
-
2005
N/A
Company Profile Activity
Activity Insights
Calando Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Calando Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Calando Pharmaceuticals.
Calando Pharmaceuticals Tech Stack
A closer look at the technologies used by Calando Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calando Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Calando Pharmaceuticals specializes in advancing RNAi therapy through its proprietary drug delivery system, RONDEL, which targets cancer treatment. The company is currently focused on hormone research, particularly HGH and HCG, in relation to sports medicine and healthy lifestyles. Their lead product, CALAA-01, is undergoing a Phase 1 clinical tria... Read More
